Skip to main content

Neuroendocrine Tumors (NETs) of the Mediastinum and Thymus

  • Chapter
  • First Online:
Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances

Abstract

Neuroendocrine tumors (NETs) of the mediastinum and thymus are rare and are usually discovered incidentally. Rosai and Higa were the first to acknowledge the existence of carcinoid tumors in the thymus and to separate them from more common tumors arising in this location, such as thymoma. The source of the primary NETs of the thymus has been proposed that they are derived from Kulchitsky cells. In this chapter we discussed the World Health Organization (WHO) classification of the NETs. We also spotlighted on some chromosomal imbalances that have been found by investigators in the most recent molecular biology literatures of the thymic NETs, as gain of chromosome (Xp, 7p, 7q, 11q, 12q, 20q, and 19p) and loss (6q, 6p, 4q, 3p, 10q, 11q, and 13q). Losses of heterozygosity (LOH) at chromosome 1p and loss of chromosomes 3, 9p21, and Y have been also reported. At the end of this chapter, we discussed the up-to-date prognosis, management, response evaluation, and follow-up of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Oberndorfer S, Oberndorfer S. Karzinoide Tumoren des Duenndarns. Frankfurt Z Pathol. 1907;1:426–30.

    Google Scholar 

  2. Gosset A, Masson P. Tumeurs endocrines de l’appendice. Presse Med. 1914;22:37–40.

    Google Scholar 

  3. Rosai J, Higa E. Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases. Cancer. 1972;29(4):1061–74. PubMed PMID: 4111691.

    Article  CAS  PubMed  Google Scholar 

  4. Rosai J, Levine G, Weber WR, Higa E. Carcinoid tumors and oat cell carcinomas of the thymus. Pathol Annu. 1976;11:201–26. PubMed PMID: 188002, Review.

    CAS  PubMed  Google Scholar 

  5. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. World Health Organization classification of tumours: pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.

    Google Scholar 

  6. Ahn S, Lee JJ, Ha SY, Sung CO, Kim J, Han J. Clinicopathological analysis of 21 thymic neuroendocrine tumors. Korean J Pathol. 2012;46(3):221–5. doi:10.4132/KoreanJPathol.2012.46.3.221. PubMed PMID: 23110006, PubMed Central PMCID: PMC3479770, Epub 2012 Jun 22.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Gaur P, Leary C, Yao JC. Thymic neuroendocrine tumors: a SEER database analysis of 160 patients. Ann Surg. 2010;251(6):1117–21. doi:10.1097/SLA.0b013e3181dd4ec4. PubMed PMID: 20485130.

    Article  PubMed  Google Scholar 

  8. Song Z, Zhang Y. Primary neuroendocrine tumors of the thymus: clinical review of 22 cases. Oncol Lett. 2014;8(5):2125–9. PubMed PMID: 25295099, PubMed Central PMCID: PMC4186590, Epub 2014 Sep 1.

    PubMed  PubMed Central  Google Scholar 

  9. Öberg K, Hellman P, Ferolla P, Papotti M, ESMO Guidelines Working Group. Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii120–3. PubMed

    Google Scholar 

  10. Viebahn R, Hiddemann W, Klinke F, von Bassewitz DB. Thymus carcinoid. Pathol Res Pract. 1985;180(4):445–51. PubMed.

    Article  CAS  PubMed  Google Scholar 

  11. Crona J, Björklund P, Welin S, Kozlovacki G, Oberg K, Granberg D. Treatment, prognostic markers and survival in thymic neuroendocrine tumours. A study from a single tertiary referral centre. Lung Cancer. 2013;79(3):289–93. doi:10.1016/j.lungcan.2012.12.001. PubMed PMID: 23286964, Epub 2013 Jan 1.

    Article  PubMed  Google Scholar 

  12. Falchetti A, Marini F, Brandi ML. Multiple endocrine neoplasia Type 1; 1993.

    Google Scholar 

  13. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79(4):813–29. PubMed PMID: 9024720.

    Article  CAS  PubMed  Google Scholar 

  14. Wick MR, Scheithauer BW. Thymic carcinoid. A histologic, immunohistochemical, and ultrastructural study of 12 cases. Cancer. 1984;53(3):475–84. PubMed PMID: 6141000.

    Article  CAS  PubMed  Google Scholar 

  15. Horie Y, Kato M. Neuroendocrine carcinoma of the posterior mediastinum: a possible primary lesion. Arch Pathol Lab Med. 1999;123(10):933–6. PubMed PMID: 10506448.

    CAS  PubMed  Google Scholar 

  16. Yajima A, Toki T, Morinaga S, Sasano H, Sasano N. A retroperitoneal endocrine carcinoma. Cancer. 1984;54(9):2040–2. PubMed PMID: 6478437.

    Article  CAS  PubMed  Google Scholar 

  17. Horenstein MG, Erlandson RA, Gonzalez-Cueto DM, Rosai J. Presacral carcinoid tumors: report of three cases and review of the literature. Am J Surg Pathol. 1998;22(2):251–5. PubMed PMID: 9500228.

    Article  CAS  PubMed  Google Scholar 

  18. Enzinger FM, Weiss SW. Peripheral neuroepithelioma. In: Soft tissue tumors. 3rd ed. New York: Mosby; 1995. p. 945–51.

    Google Scholar 

  19. Yamashita A, Marutsuka K, Moriguchi S, Shimizu T, Matsuzaki Y, Onitsuka T, Asada Y. Neuroendocrine carcinoma of the posterior mediastinum arising from a foregut cyst. Pathol Int. 2005;55(5):285–9. PubMed.

    Article  PubMed  Google Scholar 

  20. Adams S, Baum R, Rink T, Schumm-Dräger PM, Usadel KH, Hör G. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med. 1998;25(1):79–83. PubMed PMID:9396878.

    Article  CAS  PubMed  Google Scholar 

  21. Maecke HR, Hofmann M, Haberkorn U. (68)Ga-labeled peptides in tumor imaging. J Nucl Med. 2005;46 Suppl 1:172S–8. Review. PubMed PMID: 15653666.

    CAS  PubMed  Google Scholar 

  22. Phan AT, Oberg K, Choi J, Harrison Jr LH, Hassan MM, Strosberg JR, Krenning EP, Kocha W, Woltering EA, Maples WJ, North American Neuroendocrine Tumor Society (NANETS). NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax(includes lung and thymus). Pancreas. 2010;39(6):784–98. doi:10.1097/MPA.0b013e3181ec1380. PubMed PMID: 20664476.

    Article  PubMed  Google Scholar 

  23. Van Brandt V, Heyman S, Van Marck E, Hendriks J, Van Schil P. Atypical presentation of an atypical carcinoid. Ann Thorac Surg. 2009;88(6):2004–6. doi:10.1016/j.athoracsur.2009.04.124. PubMed PMID: 19932277.

    Article  PubMed  Google Scholar 

  24. Wang WQ, Ye L, Bi YF, Zhao HY, Sun SY, Tang ZY, Zhao YJ, Fang WQ, Chen ZY, Chen KM, Jin XL, Ning G. Six cases of ectopic ACTH syndrome caused by thymic carcinoid. J Endocrinol Invest. 2006;29(4):293–7. PubMed PMID: 16699293, Review.

    Article  CAS  PubMed  Google Scholar 

  25. Simsek I, Pay S, Dinc A, Erdem H, Kurt B. Atypical carcinoid tumor of the thymus with ectopic ACTH production developed during the course of etanercept treatment–case report. Clin Rheumatol. 2007;26(9):1561–2. PubMed PMID: 17061154, Epub 2006 Oct 24.

    Article  PubMed  Google Scholar 

  26. Wick MR, Scheithauer BW. Oat-cell carcinoma of the thymus. Cancer. 1982;49(8):1652–7. PubMed PMID: 6279270.

    Article  CAS  PubMed  Google Scholar 

  27. Kacar F, Meteoglu I, Sen S, Levi E. Primary neuroendocrine carcinoma of the mediastinum. Pathol Oncol Res. 2002;8(3):200–1. PubMed PMID: 12516001, Epub 2003 Jan 6.

    Article  PubMed  Google Scholar 

  28. Maeda A, Nakata M, Yasuda K, Yukawa T, Saisho S, Okita R, Hirami Y, Shimizu K. Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum. Gen Thorac Cardiovasc Surg. 2013;61(9):542–5. doi:10.1007/s11748-012-0157-5. PubMed PMID: 23011520, Epub 2012 Sep 26.

    Article  PubMed  Google Scholar 

  29. Takezawa K, Okamoto I, Fukuoka J, Tanaka K, Kaneda H, Uejima H, Yoon HE, Imakita M, Fukuoka M, Nakagawa K. Large cell neuroendocrine carcinoma of the mediastinum with alpha-fetoprotein production. J Thorac Oncol. 2008;3(2):187–9. doi:10.1097/JTO.0b013e3181623359. PubMed PMID: 18303442.

    Article  PubMed  Google Scholar 

  30. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler Jr GB, Nieman L, Chrousos G, Pass H, Doppman J. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15(6):529–53. PubMed PMID: 1709558.

    Article  CAS  PubMed  Google Scholar 

  31. Natsuhara A, Iwasaki Y, Minagawa T, Takemura Y, Nakanisi M, Nagata K, Harada H, Kubota Y, Yokomura I, Nakagawa M. Aggressively metastatic neuroendocrine carcinoma in the middle mediastinum. Nihon Kokyuki Gakkai Zasshi. 2001;39(9):705–9. Japanese. PubMed PMID: 11729693.

    CAS  PubMed  Google Scholar 

  32. Nojima D, Kiura K, Hotta K, Takigawa N, Tabata M, Tanimoto M. Large cell neuroendocrine carcinoma of the mediastinum. Nihon Kokyuki Gakkai Zasshi. 2010;48(7):506–10. Japanese. PubMed PMID: 20684214.

    PubMed  Google Scholar 

  33. Lukina O, Gorbunkov S, Dvorakovskaja I, Varlamov V, Akopov A. Fast-growing large cell neuroendocrine carcinoma of mediastinum. Ann Thorac Surg. 2011;91(5):1618–20. doi:10.1016/j.athoracsur.2010.09.065. PubMed PMID: 21524479.

    Article  PubMed  Google Scholar 

  34. Rosai J, Levine GD. Tumors of the thymus. In: Atlas of tumor pathology. Second series, Fascicle 13. Washington, DC: Armed Forces Institute of Pathology; 1976. p. 34–161.

    Google Scholar 

  35. Suster S. Mediastinal pathology. In: Weidner N, editor. The difficult diagnosis in surgical pathology. Philadelphia: Saunders; 1995. p. 143–76.

    Google Scholar 

  36. Moran CA, Suster S, Fishback N, Koss MN. Mediastinal paragangliomas. A clinicopathologic and immunohistochemical study of 16 cases. Cancer. 1993;72(8):2358–64. PubMed PMID: 8402449.

    Article  CAS  PubMed  Google Scholar 

  37. Wick MR, Rosai J. Neuroendocrine neoplasms of the mediastinum. Semin Diagn Pathol. 1991;8(1):35–51. PubMed PMID: 1646476, Review.

    CAS  PubMed  Google Scholar 

  38. Leotlela PD, Jauch A, Holtgreve-Grez H, Thakker RV. Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer. 2003;10(4):437–50. Review. PubMedPMID: 14713256.

    Article  CAS  PubMed  Google Scholar 

  39. Bi YF, Liu RX, Ye L, Fang H, Li XY, Wang WQ, Zhang J, Wang KK, Jiang L, Su TW, Chen ZY, Ning G. Gene expression profiles of thymic neuroendocrine tumors(carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism. Endocr Relat Cancer. 2009;16(4):1273–82. doi:10.1677/ERC-08-0325. Epub 2009 Jul 22. PubMed.

    Article  CAS  PubMed  Google Scholar 

  40. Rieker RJ, Aulmann S, Penzel R, Schnabel PA, Blaeker H, Esposito I, Morresi-Hauf A, Otto HF, Hecker E, Dienemann H, Schirmacher P, Mechtersheimer G. Chromosomal imbalances in sporadic neuroendocrine tumours of the thymus. Cancer Lett. 2005;223(1):169–74. Epub 2004 Dec 8. PubMed.

    Article  CAS  PubMed  Google Scholar 

  41. Teh BT, Zedenius J, Kytölä S, Skogseid B, Trotter J, Choplin H, Twigg S, Farnebo F, Giraud S, Cameron D, Robinson B, Calender A, Larsson C, Salmela P. Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg. 1998;228(1):99–105. PubMed PMID: 9671073; PubMed Central PMCID: PMC1191434.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 1972;64(3):413–21. PubMed PMID: 5054879.

    CAS  PubMed  Google Scholar 

  43. Valli M, Fabris GA, Dewar A, Chikte S, Fisher C, Corrin B, Sheppard MN. Atypical carcinoid tumour of the thymus: a study of eight cases. Histopathology. 1994;24(4):371–5. PubMed PMID: 8045526.

    Article  CAS  PubMed  Google Scholar 

  44. Öberg K, Hellman P, Ferolla P, Papotti M, ESMO Guidelines Working Group. Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii120–3. PubMed PMID: 22997444

    Google Scholar 

  45. Ekeblad S, Sundin A, Janson ET, Welin S, Granberg D, Kindmark H, Dunder K, Kozlovacki G, Orlefors H, Sigurd M, Oberg K, Eriksson B, Skogseid B. Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. Clin Cancer Res. 2007;13(10):2986–91. PubMed PMID: 17505000.

    Article  CAS  PubMed  Google Scholar 

  46. Hamada S, Masago K, Mio T, Hirota S, Mishima M. Good clinical response to imatinib mesylate in atypical thymic carcinoid with KIT overexpression. J Clin Oncol. 2011;29(1):e9–10. doi:10.1200/JCO.2010.30.2455. PubMed PMID: 20876428, Epub 2010 Sep 27.

    Article  PubMed  Google Scholar 

  47. Warren WH, Gould VE. Long-term follow-up of classical bronchial carcinoid tumors. Clinicopathologic observations. Scand J Thorac Cardiovasc Surg. 1990;24(2):125–30. PubMed PMID: 2166332.

    Article  CAS  PubMed  Google Scholar 

  48. Oberg K, Jelic S, ESMO Guidelines Working Group. Neuroendocrine bronchial and thymic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(Suppl 4):147–9. doi:10.1093/annonc/mdp157.Review. PubMed PMID: 19454438

  49. Cardillo G, Treggiari S, Paul MA, Carleo F, De Massimi AR, Remotti D, Graziano P, Martelli M. Primary neuroendocrine tumours of the thymus: a clinicopathologic and prognostic study in 19 patients. Eur J Cardiothorac Surg. 2010;37(4):814–8. doi:10.1016/j.ejcts.2009.10.026. PubMed PMID: 19954997, Epub 2009 Dec 1.

    Article  PubMed  Google Scholar 

  50. Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B, all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449(4):395–401. Epub 2006 Sep 12. PubMed PMID: 16967267; PubMed Central PMCID: PMC1888719

    Google Scholar 

  51. Fukai I, Masaoka A, Fujii Y, Yamakawa Y, Yokoyama T, Murase T, Eimoto T. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Ann Thorac Surg. 1999;67(1):208–11. PubMed PMID: 10086551.

    Article  CAS  PubMed  Google Scholar 

  52. de Montpréville VT, Macchiarini P, Dulmet E. Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg. 1996;111(1):134–41. PubMed PMID: 8551758.

    Article  PubMed  Google Scholar 

  53. Wick MR, Scott RE, Li CY, Carney JA. Carcinoid tumor of the thymus: a clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc. 1980;55(4):246–54. PubMed PMID: 6153740.

    CAS  PubMed  Google Scholar 

  54. Economopoulos GC, Lewis Jr JW, Lee MW, Silverman NA. Carcinoid tumors of the thymus. Ann Thorac Surg. 1990;50(1):58–61. PubMed PMID: 2196019, Review.

    Article  CAS  PubMed  Google Scholar 

  55. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, Koss MN. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998;22(8):934–44. PubMed PMID: 9706973.

    Article  CAS  PubMed  Google Scholar 

  56. Righi L, Volante M, Rapa I, Scagliotti GV, Papotti M. Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data. Virchows Arch. 2007;451 Suppl 1:S51–9. Epub 2007 Aug 8. Review. PubMed PMID: 17684766.

    Article  PubMed  Google Scholar 

  57. Travis WD, Giroux DJ, Chansky K, Crowley J, Asamura H, Brambilla E, Jett J, Kennedy C, Rami-Porta R, Rusch VW, Goldstraw P, International Staging Committee and Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming(seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2008;3(11):1213–23. doi:10.1097/JTO.0b013e31818b06e3. PubMed PMID: 18978555.

    Article  PubMed  Google Scholar 

  58. Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y, Yokose T, Jiang SX, Inoue T, Nakagawa K, Tajima K, Nagai K. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol. 2006;24(1):70–6. PubMed PMID:16382115.

    Article  PubMed  Google Scholar 

Download references

Abbreviations

AC Atypical carcinoid

LCNEC Large cell neuroendocrine cell carcinoma

NET Neuroendocrine tumor

SCNEC Small cell neuroendocrine cell carcinoma

TC Typical carcinoid

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sameer Al Diffalha MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Al Diffalha, S., Khalil, F. (2016). Neuroendocrine Tumors (NETs) of the Mediastinum and Thymus. In: Nasir, A., Coppola, D. (eds) Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3426-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3426-3_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3424-9

  • Online ISBN: 978-1-4939-3426-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics